Thermo Fisher Scientific

R&D

Thermo Fisher Scientific on the value of an integrated appro...

In a new sponsored video, Thermo Fisher Scientific’s Alberto Fernández discusses the company's Accelerator Drug Development solution.

R&D

12 Questions With Trenton M. Johnson

Find out more about Senior Director of CMC Portfolio Management, Thermo Fisher Scientific, Trenton M. Johnson in a new 12 Questions With.

R&D

ESMO25: On partnerships between pharma and diagnostic develo...

Jane Li, Senior Director of Pharma CDx and CRO Partnership, Clinical Next Generation Sequencing Business, at Thermo Fisher Scientific discusses CDx.

News

Thermo bids $8.9bn for clinical trial data firm Clario

Thermo Fisher Scientific has signed a deal to acquire Clario for nearly $8.9bn in cash in a major expansion of its clinical research capabilities.

Sales & Marketing

Solution Spotlight: Accelerator Drug Development

Thermo Fisher Scientific’s Accelerator Drug Development is a suite of integrated services combining CDMO and CRO to streamline drug development.

R&D

Precision medicine, NGS, and the quantum leap in biomarkers

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Luca Quagliata, Vice President and Global Head of Medical and Scientific Affairs at Thermo Fisher Scientific, a company